MGM Resorts International (NYSE:MGM)

MGM Resorts International, formerly known as MGM MIRAGE, is a global hospitality company, operating a portfolio of destination resort brands, including Bellagio, MGM Grand, Mandalay Bay and The Mirage. The Company’s resorts offer gaming, hotel, dining, entertainment, retail, and other resort amenities. It owns and operates properties located in Nevada, Mississippi and Michigan, and has investments in some properties in Nevada, Illinois and Macau. Through its hospitality management subsidiary, the Company holds a growing number of development and management agreements for casino and non-casino resort projects around the world. MGM Resorts International is based in Las Vegas, Nevada.

MGM Resorts International (NYSE:MGM)’s Financial Overview

MGM Resorts International (NYSE:MGM) surged 0.49% yesterday to close its trading session at $28.87. The company has 1 year Price Target of $32.91. MGM Resorts International has 52-Week high of $29.35 and 52-Week Low of $16.18. The stock touched its 52-Week High on Nov 21, 2016 and 52-Week Low on Feb 9, 2016. The stock traded with the volume of 8.36 Million shares yesterday. The firm shows the market capitalization of $16.55 Billion.

MGM Resorts International (NYSE:MGM) reported its last quarterly earnings on Sep 16 where the firm reported its Actual EPS of $0.58/share against the analyst consensus estimate of $0.11/share. The difference between the actual and expected EPS is $0.47 a share with a surprise factor of 427.3%.

The firm is trading with SMA20 of 4.51 Percent, SMA50 of 8.33 Percent and SMA200 of 22.17 percent. MGM Resorts International has P/S value of 1.8 while its P/B value stands at 2.65. Similarly, the company has Return on Assets of 1.1 percent, Return on Equity of 5.4 percent and Return on Investment of -0.8 Percent. The company shows Gross Margin and Operating Margin of 41.7 percent and 6.5 percent respectively.

Many brokerage firms are involved in issuing their ratings on MGM Resorts International (NYSE:MGM). On 6-Oct-16 Argus Upgrade MGM Resorts International Stock  to Buy. Another firm also rated the stock on 2-Nov-15 where UBS Upgrade the stock to Buy.

The Stock currently has Analyst’ mean Recommendation of 1.7 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.

The 16 analysts offering 12-month price forecasts for MGM Resorts International have a median target of 33.00, with a high estimate of 38.00 and a low estimate of 28.00. The median estimate represents a +14.31% increase from the last price of 28.87.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

Heat Biologics, Inc. (NASDAQ:HTBX)

Heat Biologics, Inc. is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of various cellular therapeutic vaccines for a range of cancers and infectious diseases. The Company’s products under development include HS-110 for the treatment of non-small cell lung cancer, HS-410 for the bladder cancer treatment, HS-310 to treat ovarian cancer and HS-510 for treating triple negative breast cancer. Heat Biologics, Inc. is based in Chapel Hill, North Carolina.

Heat Biologics, Inc. (NASDAQ:HTBX)’s Financial Outlook

The 2 analysts offering 12-month price forecasts for Heat Biologics Inc have a median target of 4.88, with a high estimate of 7.00 and a low estimate of 2.75. The median estimate represents a +63.59% increase from the last price of 2.98.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

According to Zacks Investment Research, Heat Biologics, Inc. has a Consensus Recommendation of 1. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).

The Stock fell -7.74% and closed its last trading session at $2.98. The company has the market capitalization of $71.13 Million. The stock has 52-week high of $4.71 and 52-Week low of $0.4. The firm touched its 52-Week high on Jan 6, 2016 and 52-Week low on May 13, 2016. The company has volume of 8.31 Million shares. The company has a total of 23.87 Million shares outstanding.

Heat Biologics, Inc. (NASDAQ:HTBX) in the last quarter reported its actual EPS of $-0.08/share where the analyst estimated EPS was $-0.15/share. The difference between the actual and Estimated EPS is $0.07. This shows a surprise factor of 46.7 percent.

The company has YTD performance of 22.13 percent. Beta for Heat Biologics, Inc. stands at 0.58 while its ATR (average true range) is 0.27. The company has Weekly Volatility of 26.38%% and Monthly Volatility of 13.90%%.

Heat Biologics, Inc. has distance from 20-day Simple Moving Average (SMA20) of 90.6%, Distance from 50-Day Simple Moving Average of 110.54 percent and Distance from 200-Day Simple Moving Average of 185.37%.

The Company currently has ROA (Return on Assets) of -140.5 percent, Return on Equity (ROE) of -316 Percent and Return on Investment (ROI) of 0% with Gross margin of 0 percent and Operating & Profit margin of 0% and 0% respectively.